< 1 minute read
Sep. 18, 2021

OATD-01: An Oral, First-In-Class CHIT1/AMCase Chitinase Inhibitor

OATD-01

oral, first-in-class CHIT1/AMCase chitinase inh. for sarcoidosis/lung fibrosis, Ph. Ib complete from opt. of literature molecule J. Med. Chem., Oct. 20, 2020 OncoArendi Therapeutics SA, Warsaw, PL

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in